Literature DB >> 4029257

Enhancement of IgG anti-carrier responses by IgG2 anti-hapten antibodies in mice.

P G Coulie, J Van Snick.   

Abstract

Isologous IgG2a and IgG2b anti-hapten antibodies injected along with trinitrophenylated or fluoresceinated keyhole limpet hemocyanin (KLH) were found to considerably stimulate primary IgG responses to the carrier protein in mice. No such stimulation was observed with IgG1, IgM and IgA anti-hapten antibodies. Depending on the antigen antibody combination, the amplification obtained after a single injection of IgG2-complexed haptenated KLH ranged from 20- to 1000-fold. By comparison, secondary responses were only marginally enhanced (approximately 3-fold) when IgG2-complexed rather than free antigen was used to boost irradiated recipients previously reconstituted with primed spleen cells. The IgG2-mediated enhancement was effective over a wide range of antigen/antibody ratios, did not require the use of high affinity antibodies and occurred whatever the route of injection. The stimulation was specific for the complexed antigen and developed to the same extent whether complexes were formed in vitro or in vivo. A comparable stimulation of the anti-carrier response was obtained with several other haptenated proteins but with formaldehyde-treated diphtheria and tetanus toxoids inhibition rather than stimulation was observed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029257     DOI: 10.1002/eji.1830150810

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

Review 1.  Functions of antibodies in the regulation of B cell responses in vivo.

Authors:  B Heyman
Journal:  Springer Semin Immunopathol       Date:  2001-12

Review 2.  Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies.

Authors:  Imre Kacskovics; Judit Cervenak; Anna Erdei; Richard A Goldsby; John E Butler
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

3.  Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice.

Authors:  M C Karlsson; S Wernersson; T Diaz de Ståhl; S Gustavsson; B Heyman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 4.  Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens.

Authors:  L Jeannine Brady
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

5.  Regulation of the anti-Sm autoantibody response in systemic lupus erythematosus mice by monoclonal anti-Sm antibodies.

Authors:  R A Eisenberg; D S Pisetsky; S Y Craven; J P Grudier; M A O'Donnell; P L Cohen
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

6.  Immunogenicity of protein therapeutics: The key causes, consequences and challenges.

Authors:  Matthew P Baker; Helen M Reynolds; Brooke Lumicisi; Christine J Bryson
Journal:  Self Nonself       Date:  2010-10

7.  Presentation by peritoneal macrophages: modulation by antibody-antigen complexes.

Authors:  K A Perkins; B M Chain
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

8.  FcRn overexpression in mice results in potent humoral response against weakly immunogenic antigen.

Authors:  Attila Végh; Judit Cervenak; István Jankovics; Imre Kacskovics
Journal:  MAbs       Date:  2011-03-01       Impact factor: 5.857

9.  CD8+ cells suppress oil-induced arthritis.

Authors:  A M Jansson; J C Lorentzen; A Bucht
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

10.  C3- and T-cell-dependent adjuvant activity of in vivo formed immune complexes.

Authors:  C W Van den Berg; M A Hazenberg; F M Hofhuis; S M Van Rooyen; H Van Dijk
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.